Cosmos Health (COSM) announced that it has entered into a Letter of Intent, LOI, through its wholly owned subsidiary CosmoFarm S.A., with respect to the acquisition of an extensive pharmacy distribution network from an established pharmaceutical company serving the Greek market. The term of the LOI is ninety days from March 6, 2026. The network currently generates approximately EUR 10 million in annual gross revenue and serves a broad base of pharmacy customers, supplying both pharmaceutical and para-pharmaceutical products.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COSM:
- Cosmos Health announces C-Scrub availability at Tesco
- Crypto Currents: Coinbase, Robinhood post Q4 results
- Cosmos Health purchases $500,000 of bitcoin
- Cosmos Health sees expansion supporting $40M in additional annual revenue